Market evolution: Medical dressings (CN 3005) — 2015–2025

Introduction

This report analyzes the evolution of the European Union's external trade in medical dressings and related products (Customs Code 3005) over the decade from 2015 to 2025. The analysis covers trade values, volumes, prices, partner dynamics, and structural shifts within the EU. The data reveals a period of significant growth and strategic rebalancing, transforming the EU's position in the global market for these essential medical goods.

Export-Led Growth and a Dramatic Rebalancing of Trade

The most striking trend over the period is the robust growth of EU exports, which outpaced import growth significantly. This dynamic transformed the EU from a net importer of medical dressings at the start of the period to a strong net exporter by 2025. The surge was driven by a combination of volume growth and a substantial increase in export unit values.

EU Exports Outpaced Imports in Both Volume and Value

EU exports of CN 3005 products grew strongly across all metrics. The total export value increased by 74.7%, rising from €1.01 billion in 2015 to €1.77 billion in 2025. While export volume also grew by 20.8%, the more pronounced increase in value was propelled by a 44.6% rise in the average export price (from €26,384 per tonne to €38,143 per tonne).

In contrast, import growth was more moderate. Import value grew by 23.4% (from €1.09 billion to €1.35 billion), closely tracking the 22.6% growth in import volume. The average import price saw negligible change over the decade.

Source: EU Trade Overview for CN 3005

The EU Shifted from a Net Importer to a Major Net Exporter

The differential growth rates fundamentally altered the EU's trade balance. In 2015, the EU had a trade deficit of €82 million. By 2025, this had transformed into a substantial surplus of €418 million. This shift is also reflected in the net import reliance metric, which moved from a positive 9.1% (indicating reliance on imports) in 2015 to a negative -17.1% in 2025 (indicating a net exporter position).

Evolving Trade Partnerships and Rising Concentration

The geographical landscape of EU trade underwent significant changes, characterized by deepening ties with a few major partners and increased concentration in sourcing.

China Solidified its Role as the Dominant Import Source

China was the EU's largest supplier throughout the period, with import values growing by 79.7% to reach €663 million in 2025. The United States remained the second-largest partner, with imports growing by 19.8%. The UK's share of EU imports fell by 18.1%, likely reflecting post-Brexit trade dynamics. Notably, imports from Mexico collapsed by 82.1% over the period.

Source: Top Import Partners

The US Became the Premier Export Market for the EU

On the export side, the United States saw explosive growth, becoming the EU's top destination with export values surging by 142.9% to €598 million in 2025. Exports to other key partners like Australia (+47.7%) and Switzerland (+20.0%) also grew robustly. The UK remained a stable, high-value market, with a modest 4.1% increase.

Source: Top Export Partners

Trade Concentration Increased for Imports but Remained Stable for Exports

The Herfindahl-Hirschman Index (HHI) for import value increased by 35.6% from 2,252 to 3,054, indicating rising concentration and a greater reliance on a smaller number of supplier countries, primarily China. In contrast, the export HHI saw only a minor 9.1% increase, suggesting the EU successfully diversified its export markets despite the rapid growth in shipments to the US.

Structural Shifts in EU Production and Specialization

Behind the trade figures, the EU's internal production structure and competitive advantages evolved, underpinning its improved export performance.

EU Production Value Grew, Supporting Export Capacity

EU production value for CN 3005 products increased by 30.7% from €2.06 billion in 2015 to €2.69 billion in 2025. This growth in domestic manufacturing capacity provided the foundation for the substantial increase in exports, allowing the EU to service growing international demand, particularly from the US.

Specialization Varies Widely Across EU Member States

Analysis of export specialization in 2025 reveals significant disparities among member states. Finland, Hungary, and Czechia show high levels of specialization (Revealed Symmetric Comparative Advantage - RSCA > 0.29), meaning their export profiles are heavily focused on medical dressings relative to their overall trade. Conversely, countries like Cyprus, Croatia, and Romania have low specialization scores, indicating their exports are not concentrated in this product category.

The Netherlands and Hungary Emerged as Key EU Trade Hubs

Within the EU, the Netherlands saw the most dramatic growth in both imports (+95.6%) and exports (+423.0%) over the period, cementing its role as a major logistics and trade hub. Hungary also witnessed a remarkable 1070.6% increase in export value. Meanwhile, traditional hubs like Germany maintained large but more stable trade volumes.

Conclusion

Between 2015 and 2025, the EU's medical dressings market underwent a profound transformation. The bloc evolved from a net importer to a significant net exporter, driven by strong export growth in both volume and, especially, value. This shift was supported by increased domestic production capacity and high specialization in several member states.

The trade landscape became more concentrated on the import side, with China deepening its role as the primary supplier. On the export side, the EU successfully capitalized on surging demand from the United States, which became its largest market by a significant margin. The data suggests a strategic repositioning, where the EU not only met its own needs but also leveraged its production capabilities to become a major global supplier of higher-value medical dressing products.